+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 60Years +
All Genders
ID07087951

Evaluating an Innovative 40 Hz Gamma Auditory Stimulation Device for Older Adults with Cognitive Decline Using a Randomized, Double-Blind, Placebo-Controlled Design

Led by Chang Gung Memorial Hospital · Updated on 2026-08-17

70

Participants Needed

1

Research Sites

8 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying the effects of 40 Hz auditory stimulation on cognitive function, brain activity, sleep quality, and quality of life in older adults with mild cognitive impairment or mild dementia. This study uses a randomized, double-blind, placebo-controlled design to better understand how this type of sound stimulation might influence these aspects in people experiencing early cognitive decline. The study is motivated by previous findings that 40 Hz visual stimulation can improve brain function but has limitations related to discomfort and practicality, which auditory stimulation may overcome. Participants will be randomly assigned to one of two groups one receiving 40 Hz auditory stimulation combined with music, and the other receiving a non-40 Hz sham stimulation combined with music. Each participant will use the gamma auditory stimulation device for one hour per day, five days a week, over a 12-week period, totaling 60 hours of stimulation. The study will compare the effects of the active 40 Hz stimulation against the sham control to evaluate cognitive and neurological outcomes. Throughout the study, participants will undergo various assessments including cognitive tests, EEG monitoring, and questionnaires on sleep quality and quality of life at baseline, after completing the intervention, and three months post-intervention. Researchers will measure changes in neurophysiological function and performance on several cognitive and mood scales. Safety and device feasibility will also be monitored during the three-month intervention period. The total duration of participation extends to about six months including follow-up assessments.

CONDITIONS

Brief Title

Efficacy of Gamma Auditory Stimulation for Cognitive Decline in Older Adults (Study 1)

Research Team

C

Chia-Hsiung Cheng, Ph.D.

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here